Brokerages expect Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to report $616.42 million in sales for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Jazz Pharmaceuticals’ earnings, with estimates ranging from $598.29 million to $648.60 million. Jazz Pharmaceuticals posted sales of $534.73 million during the same quarter last year, which suggests a […]
